The Effect of Different Doses of Ciprofol in Patients with Painless Gastrointestinal Endoscopy
Lini Chen,Yongguo Xie,Xueke Du,Weiyong Qin,Lifu Huang,Junmin Dai,Ke Qin,Jianfeng Huang
DOI: https://doi.org/10.2147/DDDT.S414166
2023-06-12
Abstract:Lini Chen, &ast Yongguo Xie, &ast Xueke Du, Weiyong Qin, Lifu Huang, Junmin Dai, Ke Qin, &ast Jianfeng Huang &ast Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ke Qin; Jianfeng Huang, Department of Anesthesiology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China, Tel/Fax +8613878103578 ; +8613978896039, Email ; Background: Ciprofol is currently used for painless gastrointestinal endoscopy and anesthesia induction. However, whether it is superior to propofol and its optimal dose remains unknown. Methods: A total of 149 patients, 63 males and 86 females, aged 18– 80 years, BMI 18– 28 kg/m 2 , ASA I–III, were divided randomly into four groups: propofol group (group P, n = 44), ciprofol 0.2mg/kg group (group C2, n = 38), ciprofol 0.3mg/kg group (group C3, n = 36) and ciprofol 0.4 mg/kg group (group C4, n = 31). Groups C2, C3 and C4 had injected IV with ciprofol 0.2, 0.3 and 0.4 mg/kg, respectively. Group P had injected IV with propofol 1.5mg/kg. The time for disappearance of the eyelash reflex, gastrointestinal endoscopy time, recovery time, and the Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score at awakening (T 1 ), 15 minutes after awakening (T 2 ) and 30 minutes after awakening (T 3 ) were recorded. Results: Compared with group P, the time to fall asleep was significantly shortened, and the incidence of nausea and vomiting and injection pain was significantly lower in groups C2, C3 and C4 ( P 0.05). Compared with group P and C4, the incidence of hypotension and respiratory depression was significantly lower in groups C2 and C3 ( P < 0.05). Conclusion: The appropriate dose of ciprofol for painless gastrointestinal endoscopy is more advantageous than propofol in hemodynamics and respiratory stability, with less injection pain and nausea and vomiting, which is worthy of clinical promotion. Keywords: ciprofol, propofol, painless gastrointestinal endoscopy With the rapid development of medicine and the promotion of comfort medicine, painless gastrointestinal endoscopy has been widely used in clinics. As one of the most commonly used drugs for sedation, propofol has pharmacokinetic properties such as fast onset and rapid elimination. In painless gastrointestinal endoscopies, it is however limited by their high incidence of hypotension, respiratory depression, and injection pain. The latest 2,6-disubstituted phenol derivative, ciprofol, was independently developed in China and is currently used for painless gastrointestinal endoscopy and anesthesia induction. 1 Although ciprofol has a similar sedative effect as propofol, it has a clear absorption, distribution, metabolism and excretion processes, a low incidence of hypotension and respiratory depression, and a high level of safety. 2 Therefore, the aim of this study was to compare different doses of ciprofol and propofol used in painless gastrointestinal endoscopy in order to determine the appropriate dose of ciprofol, improve the sedation mode of painless gastrointestinal endoscopy, reduce the incidence of related complications, and provide reference for painless gastrointestinal endoscopy. This was a prospective, single-blinded, randomized controlled clinical trial. It was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Second Affiliated Hospital of Guangxi medical University (KY-2022-0502). It was registered at the Chinese Clinical Trials Registry (ChiCTR2200063410). Signed, informed consent to participate in the study was obtained from the patients and their families before the operation. The study was a prospective, randomized, single-blind study conducted on 160 patients who underwent elective painless gastrointestinal endoscopy, and was aged 18–80 years, with a body mass index (BMI) of 18–28 kg/m 2 and an American Society of Anesthesiology physical status (ASA PS) of I–III. Patients were excluded according to the following criteria: patients with mental and nervous system diseases, heart failure, respiratory failure, long-term use of sedatives or antidepressants, pregnant or lactating women, and unable to communicate or cooperate. Patients were withdrawn from the study according to the following criteria: endoscopic operation fails, gastroscopy combined with colonoscopy examination, change to tracheal intubati -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal